Stability Studies for Specific Dosage Forms

Stability Testing for Solid Dosage Forms (Tablets, Capsules)

Solid oral dosage forms, particularly tablets and capsules, represent the most common pharmaceutical formulations due to their convenience, patient compliance, and manufacturing scalability. Despite their apparent stability, these forms are not immune to degradation. Factors such as moisture uptake, temperature sensitivity, and packaging interactions can affect their physical and chemical integrity over time. Stability testing is therefore essential to ensure consistent efficacy, safety, and quality throughout a product’s shelf life.
Click to read the full article.

Stability Studies for Specific Dosage Forms, Stability Testing for Solid Dosage Forms (Tablets, Capsules)

Stability Considerations for Liquid and Injectable Drugs

Liquid and injectable pharmaceutical products—whether sterile solutions, emulsions, or reconstituted powders—require rigorous stability assessment due to their complex physicochemical characteristics and heightened sensitivity to environmental and container-related factors. Unlike solid dosage forms, these products often demand specialized protocols to evaluate microbial contamination risk, phase separation, pH drift, and particulate formation. Regulatory bodies worldwide, including FDA, EMA, and WHO, mandate robust, dosage-specific stability data to ensure product safety and efficacy throughout the intended shelf life.
Click to read the full article.

Stability Considerations for Liquid and Injectable Drugs, Stability Studies for Specific Dosage Forms

Stability Studies for Specific Dosage Forms: Tailored Approaches for Regulatory Compliance

Stability Studies are an essential component of pharmaceutical product development and regulatory submission. While ICH guidelines provide a unified framework for stability testing, each pharmaceutical dosage form—be it oral solid, injectable, topical, ophthalmic, or biologic—presents unique challenges due to its formulation, packaging, and route of administration. Tailoring stability protocols to the characteristics of specific dosage forms ensures accurate shelf life estimation, packaging compatibility, and global regulatory acceptance.
Click to read the full article.

Stability Studies for Specific Dosage Forms

Ophthalmic and Inhalation Product Stability Studies: Regulatory and Technical Guidance

Stability Studies for ophthalmic and inhalation products require specialized protocols due to their complex formulation types, unique delivery systems, and critical quality attributes. Unlike conventional dosage forms, ophthalmic drops and inhalation therapies—such as metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nasal sprays—must meet stringent requirements related to sterility, particle size distribution, microbial integrity, and in-use stability. Ensuring consistent product performance over shelf life is not only a regulatory necessity but essential for patient safety and therapeutic effectiveness.
Click to read the full article.

Ophthalmic and Inhalation Product Stability Studies, Stability Studies for Specific Dosage Forms

Photostability and Humidity Impact on Semi-Solid Dosage Forms

Semi-solid pharmaceutical dosage forms—such as creams, ointments, gels, and pastes—are commonly used for topical and mucosal drug delivery. While these formulations offer localized treatment with improved patient compliance, they are inherently vulnerable to environmental factors like light and humidity. Photodegradation can alter drug potency or generate toxic degradation products, while high humidity can induce phase separation, microbial contamination, or changes in consistency and efficacy.
Click to read the full article.

Photostability and Humidity Impact on Semi-Solid Dosage Forms, Stability Studies for Specific Dosage Forms

Challenges in Stability Testing for Liposomal and Nanoparticle Formulations

Liposomal and nanoparticle-based drug delivery systems represent a significant advancement in pharmaceutical sciences, offering targeted delivery, improved bioavailability, and enhanced pharmacokinetics. However, their complex physicochemical nature poses significant challenges for long-term stability. From vesicle integrity and particle aggregation to leakage of active pharmaceutical ingredients (APIs) and lipid oxidation, stability testing of these systems must be comprehensive and scientifically robust.
Click to read the full article.

Challenges in Stability Testing for Liposomal and Nanoparticle Formulations, Stability Studies for Specific Dosage Forms